Apotex Health Corp. (APTX.TO) Stock Overview
Explore Apotex Health Corp.’s financial performance, market position, analyst ratings, and future outlook.
Apotex Health Corp. (APTX.TO)
Key Financials
Key Financials
Market Cap
7.6B
P/E Ratio
20.58
EPS (TTM)
$1.61
ROE
-2.80%
APTX.TO Stock Analysis & Investment Overview (TSX)
Our AI-powered analysis of Apotex Health Corp. (TSX: APTX.TO) gives investors deep insight into how the stock performs on the TSX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Apotex Health Corp.'s TSX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of APTX.TO on the TSX shows an RSI of 31.94, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $95.02 for the TSX listing.
Key metrics behind Apotex Health Corp.'s TSX-traded stock include a P/E ratio of 20.58 and a market capitalization of 7.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of APTX.TO on the TSX.